Table 1

Comparative levels of markers of plasminogen oxidative damage and glycation between control and diabetic samples at baseline

AnalyteHealthy controls (n = 12)Subjects with T1DM (baseline, n = 9)P
FLPlasminogen, mol% 1.82 ± 0.95 6.26 ± 3.43 <.01 
MG-H1Plasminogen, mol% 0.37 ± 0.12 0.52 ± 0.40 >.1 
CMLPlasminogen, mol% 0.58 ± 0.27 0.49 ± 0.14 >.1 
Methionine sulfoxidePlasminogen, mol% 6.37 ± 2.79 8.17 ± 4.64 >.1 
AnalyteHealthy controls (n = 12)Subjects with T1DM (baseline, n = 9)P
FLPlasminogen, mol% 1.82 ± 0.95 6.26 ± 3.43 <.01 
MG-H1Plasminogen, mol% 0.37 ± 0.12 0.52 ± 0.40 >.1 
CMLPlasminogen, mol% 0.58 ± 0.27 0.49 ± 0.14 >.1 
Methionine sulfoxidePlasminogen, mol% 6.37 ± 2.79 8.17 ± 4.64 >.1 
Close Modal

or Create an Account

Close Modal
Close Modal